Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

513 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival.
Gouin F, Ory B, Rédini F, Heymann D. Gouin F, et al. Among authors: heymann d. Int J Cancer. 2006 Sep 1;119(5):980-4. doi: 10.1002/ijc.21951. Int J Cancer. 2006. PMID: 16570273
[Modulation of integrin alpha-v-beta-1 expression on human tumor cells by leukemia inhibitory factor (LIF) and oncostatin M (OSM)].
Heymann D, Harb J, Ringeard S, Blanchard F, Lassort D, Raher S, Godard A. Heymann D, et al. Bull Cancer. 1996 Jan;83(1):13-21. Bull Cancer. 1996. PMID: 8672851 Review. French.
Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
Gouin F, Moreau A, Couillaud S, Guicheux J, Passuti N, Godard A, Heymann D. Gouin F, et al. Among authors: heymann d. J Orthop Res. 1999 Mar;17(2):301-5. doi: 10.1002/jor.1100170221. J Orthop Res. 1999. PMID: 10221849
Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma.
Grimaud E, Damiens C, Rousselle AV, Passuti N, Heymann D, Gouin F. Grimaud E, et al. Among authors: heymann d. Histol Histopathol. 2002 Oct;17(4):1103-11. doi: 10.14670/HH-17.1103. Histol Histopathol. 2002. PMID: 12371138
Metatarsal giant cell tumors and giant cell reparative granuloma are similar entities.
Gouin F, Grimaud E, Redini F, Moreau A, Passuti N, Heymann D. Gouin F, et al. Among authors: heymann d. Clin Orthop Relat Res. 2003 Nov;(416):278-84. doi: 10.1097/01.blo.0000093016.90435.f6. Clin Orthop Relat Res. 2003. PMID: 14646771
Bisphosphonates: new therapeutic agents for the treatment of bone tumors.
Heymann D, Ory B, Gouin F, Green JR, Rédini F. Heymann D, et al. Trends Mol Med. 2004 Jul;10(7):337-43. doi: 10.1016/j.molmed.2004.05.007. Trends Mol Med. 2004. PMID: 15242682 Review.
Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools.
Heymann D, Fortun Y, Rédini F, Padrines M. Heymann D, et al. Drug Discov Today. 2005 Feb 15;10(4):242-7. doi: 10.1016/S1359-6446(04)03265-9. Drug Discov Today. 2005. PMID: 15708742 Review.
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.
Heymann D, Ory B, Blanchard F, Heymann MF, Coipeau P, Charrier C, Couillaud S, Thiery JP, Gouin F, Redini F. Heymann D, et al. Among authors: heymann mf. Bone. 2005 Jul;37(1):74-86. doi: 10.1016/j.bone.2005.02.020. Bone. 2005. PMID: 15894525
A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations.
Cherrier B, Gouin F, Heymann MF, Thiéry JP, Rédini F, Heymann D, Duteille F. Cherrier B, et al. Among authors: heymann mf, heymann d. Tumour Biol. 2005 May-Jun;26(3):121-30. doi: 10.1159/000086483. Epub 2005 Jun 17. Tumour Biol. 2005. PMID: 15970646
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.
Théoleyre S, Mori K, Cherrier B, Passuti N, Gouin F, Rédini F, Heymann D. Théoleyre S, et al. Among authors: heymann d. BMC Cancer. 2005 Sep 27;5:123. doi: 10.1186/1471-2407-5-123. BMC Cancer. 2005. PMID: 16188028 Free PMC article.
513 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page